- 专利标题: Ocular drug delivery
-
申请号: US16955336申请日: 2018-12-21
-
公开(公告)号: US11779543B2公开(公告)日: 2023-10-10
- 发明人: Gautam Behl , Sangeeta Kumari , Niall O'Reilly , Orla O'Donovan , Peter McLoughlin , David Kent , Laurence Fitzhenry , Elke Behaeghel
- 申请人: Waterford Institute of Technology
- 申请人地址: IE Waterford
- 专利权人: Waterford Institute of Technology
- 当前专利权人: Waterford Institute of Technology
- 当前专利权人地址: IE Waterford
- 代理机构: Lee & Hayes, P.C.
- 优先权: GB 21832 2017.12.22
- 国际申请: PCT/IB2018/060528 2018.12.21
- 国际公布: WO2019/123420A 2019.06.27
- 进入国家日期: 2020-06-18
- 主分类号: A61K9/51
- IPC分类号: A61K9/51 ; A61F9/00 ; A61K9/00 ; A61K31/573 ; A61K45/06 ; B82Y5/00
摘要:
This invention relates to a Nanostructured Lipid Carrier (NLC) particle comprising a therapeutic agent encapsulated therein for ocular delivery of the therapeutic agent, wherein the Nanostructured Lipid Carrier comprises: (i) a solid outer shell comprising a solid lipid, and (ii) a liquid core comprising a liquid lipid; and wherein the core comprises the therapeutic agent. Compositions of the NLC particles, use of the NLC particles, methods of treatment or prevention of an eye disorder and an eye drop dispenser are also provided.
公开/授权文献
- US20210085618A1 OCULAR DRUG DELIVERY 公开/授权日:2021-03-25
信息查询